ABOS peer analysis
Acumen Pharmaceuticals (ABOS) against its competitors: price, today's move, 1-year return and market value side by side.
- ABOS's peers: ACTU (Actuate Therapeutics), AGEN (Agenus), ALEC (Alector), FATE (Fate Therapeutics), INO (Inovio Pharmaceuticals), IRD (Opus Genetics), MCRB (Seres Therapeutics), SEER (Seer).
ABOS and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACTU Actuate Therapeutics | $0.21 | -12.95% | -96.35% | $5.13M |
| AGEN Agenus | $5.90 | -3.91% | 40.48% | $266.95M |
| ALEC Alector | $2.33 | 1.52% | 91.39% | $347.63M |
| FATE Fate Therapeutics | $0.96 | -5.06% | -8.68% | $116.57M |
| INO Inovio Pharmaceuticals | $1.84 | 7.60% | 3.37% | $127.13M |
| IRD Opus Genetics | $3.87 | -5.17% | 108.01% | $373.95M |
| MCRB Seres Therapeutics | $1.33 | -7.64% | -95.35% | $13.56M |
| SEER Seer | $1.39 | -3.82% | -30.75% | $77.30M |
| SPRO Spero Therapeutics | $0.83 | -5.46% | -65.28% | $48.14M |
| VTGN Vistagen Therapeutics | $0.19 | -6.47% | -95.85% | $8.62M |
| ABOS Acumen Pharmaceuticals | $0.18 | -9.11% | -88.66% | $12.71M |